Gsk (GSK) Cash & Equivalents Growth (3y) (2012 - 2026)
Powered by 
Analysis
Gsk (GSK) Cash & Equivalents Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Asml Holding | 618.86 Bn | 602.88 Bn | 5.90 Bn | 27.88% |
| 2 | Hsbc Holdings | 361.40 Bn | 361.40 Bn | - | - |
| 3 | General Electric | 329.38 Bn | 320.03 Bn | 6.95 Bn | -9.88% |
| 4 | Astrazeneca | 253.73 Bn | 248.44 Bn | 12.86 Bn | -4.76% |
| 5 | Citigroup | 228.07 Bn | -2,074.24 Bn | 24.75 Bn | - |
| 6 | Bhp | 216.09 Bn | 197.55 Bn | - | 14.25% |
| 7 | Rio Tinto | 203.71 Bn | 199.33 Bn | - | -0.98% |
| 8 | Diageo | 197.36 Bn | 195.32 Bn | - | -5.49% |
| 9 | Unilever | 139.15 Bn | 132.12 Bn | - | 0.34% |
| 10 | Gsk | 101.53 Bn | 101.53 Bn | 15.97 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.97% |
| Mar 31, 2026 | 9.72% |
| Dec 31, 2025 | 1.15% |
| Sep 30, 2025 | 1.53% |
| Jun 30, 2025 | -16.14% |
| Mar 31, 2025 | 122.19% |
| Dec 31, 2024 | -4.82% |
| Sep 30, 2024 | -4.49% |
| Jun 30, 2024 | -8.60% |
| Mar 31, 2024 | -18.59% |
| Dec 31, 2023 | -24.02% |
| Jun 30, 2023 | -27.09% |
| Mar 31, 2023 | -16.86% |
| Dec 31, 2022 | -10.31% |
| Sep 30, 2022 | -7.15% |
| Jun 30, 2022 | 15.36% |
| Mar 31, 2022 | -54.33% |
| Dec 31, 2021 | 4.94% |
| Sep 30, 2021 | -1.25% |
| Jun 30, 2021 | -3.87% |